MedPath

Investigation of effectiveness of radiofrequency ablation in beta thalassemia patients, considering hematologic parameters

Not Applicable
Conditions
Beta thalassemia.
Cooley's anaemia
Registration Number
IRCT138712141738N1
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
38
Inclusion Criteria

beta thalassemia
Exclusion criteria: positive direct or indirect coombs

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
evel of Hb. Timepoint: 3 month follow-up period. Method of measurement: CBC.;Platelet count. Timepoint: 3 month follow-up period. Method of measurement: CBC.
Secondary Outcome Measures
NameTimeMethod
eed to transfusion. Timepoint: 3 months follow-up period. Method of measurement: transfusion volume and intervals.
© Copyright 2025. All Rights Reserved by MedPath